title: Searching for new strategies for the pharmacological treatment of chronic pain.
abstract: Chronic pain is poorly managed and represents a huge unmet medical need that affects humans globally. The traditional multifaceted drug regimens for controlling chronic pain are marginally effective, produce highly variable results and display for the most parts unacceptable side effects. Research efforts over the last decade have identified peroxynitrite (PN) as a critical signaling molecule in the development of pain. Targeting PN is a novel evidence-based approach to develop novel therapeutics for managing chronic pain.
authors.affiliation: Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, USA. salvemd@slu.edu
authors.forename: Daniela
authors.initials: D
authors.lastname: Salvemini
mesh_terms: D000975:Antioxidants / Q000494:pharmacology / Q000627:therapeutic use; D002908:Chronic Disease; D016166:Free Radical Scavengers / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D018384:Oxidative Stress / Q000187:drug effects; D010146:Pain / Q000188:drug therapy* / Q000378:metabolism; D030421:Peroxynitrous Acid / Q000502:physiology*; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism
chemical_list: D000975:Antioxidants; D016166:Free Radical Scavengers; D016194:Receptors, N-Methyl-D-Aspartate; D030421:Peroxynitrous Acid
references.citation: Arch Biochem Biophys. 2009 Apr 15;484(2):238-44
references.pmid: 19017525
references.citation: Neuroscience. 2002;111(2):389-97
references.pmid: 11983324
references.citation: Anticancer Drugs. 1995 Apr;6 Suppl 3:4-13
references.pmid: 7606036
references.citation: Pain. 2004 May;109(1-2):132-42
references.pmid: 15082135
references.citation: Cell Mol Life Sci. 2000 Oct;57(11):1489-92
references.pmid: 11092442
references.citation: Nat Rev Drug Discov. 2002 May;1(5):367-74
references.pmid: 12120412
references.citation: J Neurosci. 2008 Sep 17;28(38):9486-94
references.pmid: 18799680
references.citation: Nat Rev Drug Discov. 2003 Mar;2(3):175-6
references.pmid: 12619637
references.citation: Pain Med. 2001 Mar;2(1):8-14
references.pmid: 15102312
references.citation: Nat Rev Drug Discov. 2007 Aug;6(8):662-80
references.pmid: 17667957
references.citation: Curr Opin Investig Drugs. 2002 Mar;3(3):441-8
references.pmid: 12054094
references.citation: Life Sci. 2010 Apr 10;86(15-16):604-14
references.pmid: 19576230
references.citation: Trends Pharmacol Sci. 2009 Apr;30(4):194-202
references.pmid: 19261337
references.citation: Drugs. 2003;63(15):1549-63
references.pmid: 12887262
references.citation: J Clin Invest. 2006 Jan;116(1):4-15
references.pmid: 16395396
references.citation: Br J Pharmacol. 2003 Oct;140(3):445-60
references.pmid: 14522841
references.citation: J Pharmacol Exp Ther. 2004 Jun;309(3):869-78
references.pmid: 14988418
references.citation: Antioxid Redox Signal. 2010 Sep 15;13(6):877-918
references.pmid: 20095865
references.citation: Drug News Perspect. 1998 May;11(4):204-14
references.pmid: 15616662